Table II.
Association of ANKHD1 expression with clinical and pathological factors in NSCLC.
| Clinicopathological factors | N | ANKHD1, n (%)
|
P-value | |
|---|---|---|---|---|
| Negative | Positive | |||
| Total | 170 | 53 (31.2) | 117(68.8) | |
| Age, years | 0.615 | |||
| ≤55 | 66 | 19 (11.2) | 47 (27.6) | |
| >55 | 104 | 34 (20.0) | 70 (41.2) | |
| Sex | 0.740 | |||
| Male | 94 | 28 (16.5) | 66 (38 .8) | |
| Female | 76 | 25 (14.7) | 51 (30.0) | |
| Histological type | 0.743 | |||
| Squamous cell carcinoma | 77 | 20(11.8) | 57 (33.5) | |
| Adenocarcinoma | 93 | 33 (19.4) | 60 (35.3) | |
| Grade | 0.188 | |||
| Well differentiated | 44 | 10 (5.9) | 34 (20.0) | |
| Moderately/poorly differentiated | 126 | 43 (25.3) | 83 (48.8) | |
| TNM stage | 0.019 | |||
| I and II | 73 | 30 (17.6) | 43 (25.3) | |
| III and IV | 97 | 23 (13.5) | 74 (43.5) | |
| Tumor size, cm | 0.862 | |||
| <3 | 58 | 19 (11.2) | 39 (22.9) | |
| ≥3 | 112 | 34 (20.0) | 78 (45.9) | |
| Lymph node metastasis | 0.020 | |||
| Yes | 81 | 17 (10.0) | 64 (37.6) | |
| No | 89 | 36 (21.2) | 53 (31.2) | |